Cancer-targeting drug conjugates drives a new era in precise cancer treatment
Jia Deng(Shenyang Pharmaceutical University), Cong Luo(Chongqing University), Haowen Tian(Northwestern Polytechnical University), Na Liu(Shenyang Pharmaceutical University), Jianbin Shi(Shenyang Pharmaceutical University), Jinrui Liu(China Earthquake Administration), Dan Li(Zhejiang Provincial People's Hospital), Jiao Xue(Jinzhou Medical University), Ken‐ichiro Kamei(Shenyang Pharmaceutical University)
Cited by 7
Related Papers
Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy
|Journal of Controlled Release|2019|162
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
|Biomedicine & Pharmacotherapy|2024|109
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
|Journal of Nanobiotechnology|2022|82
Nimodipine nanocrystals for oral bioavailability improvement: Preparation, characterization and pharmacokinetic studies
|Colloids and Surfaces B Biointerfaces|2013|77
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
|Nature Communications|2023|65